Terms: = Germ cell tumor AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1
64 results:
1. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
Björk JR; Bolte LA; Maltez Thomas A; Lee KA; Rossi N; Wind TT; Smit LM; Armanini F; Asnicar F; Blanco-Miguez A; Board R; Calbet-Llopart N; Derosa L; Dhomen N; Brooks K; Harland M; Harries M; Lorigan P; Manghi P; Marais R; Newton-Bishop J; Nezi L; Pinto F; Potrony M; Puig S; Serra-Bellver P; Shaw HM; Tamburini S; Valpione S; Waldron L; Zitvogel L; Zolfo M; de Vries EGE; Nathan P; Fehrmann RSN; Spector TD; Bataille V; Segata N; Hospers GAP; Weersma RK
Nat Med; 2024 Mar; 30(3):785-796. PubMed ID: 38365950
[TBL] [Abstract] [Full Text] [Related]
2. Administration of a glypican-3 peptide increases the infiltration and cytotoxicity of CD8
Zhao J; Qin L; He G; Xie T; Hu G; Wang F; Zhong H; Zhu J; Xu Y
Cancer Med; 2023 Dec; 12(23):21293-21307. PubMed ID: 37986544
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
4. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Di Filippo G; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674
[TBL] [Abstract] [Full Text] [Related]
5. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma.
Donizy P; Krzyzinski M; Markiewicz A; Karpinski P; Kotowski K; Kowalik A; Orlowska-Heitzman J; Romanowska-Dixon B; Biecek P; Hoang MP
Eur J Cancer; 2022 Oct; 174():251-260. PubMed ID: 36067618
[TBL] [Abstract] [Full Text] [Related]
7. Glypican-3 (gpc3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma.
Muralidharan S; Kervarrec T; Weiss GJ; Samimi M
Oncotarget; 2022; 13():960-967. PubMed ID: 35937502
[TBL] [Abstract] [Full Text] [Related]
8. Yolk Sac tumor Originating From Cervical Adenocarcinoma: A Case Predominated by Enteroblastic Differentiation.
Liu XL; Ding L; Lu X; Hu YJ; Zhou XL; Lin DL
Int J Gynecol Pathol; 2023 Mar; 42(2):212-216. PubMed ID: 35639370
[TBL] [Abstract] [Full Text] [Related]
9. Urachal yolk sac tumor penetrating the bladder as a diagnostic challenge: a case report and review of the literature.
Šámal V; Jirásek T; Paldus V; Richter I; Hes O
Diagn Pathol; 2022 Jan; 17(1):8. PubMed ID: 35027045
[TBL] [Abstract] [Full Text] [Related]
10. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach.
Fichtner A; Richter A; Filmar S; Kircher S; Rosenwald A; Küffer S; Nettersheim D; Oing C; Marx A; Ströbel P; Bremmer F
Histopathology; 2022 Jan; 80(2):381-396. PubMed ID: 34506648
[TBL] [Abstract] [Full Text] [Related]
11. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
[TBL] [Abstract] [Full Text] [Related]
12. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors.
Gallo A; Fankhauser C; Hermanns T; Beyer J; Christiansen A; Moch H; Bode PK
Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848
[TBL] [Abstract] [Full Text] [Related]
13. [Social rights claims for malignant melanoma patients : Providing patient information in german dermatological practices].
Zander N; Krensel M; Schäfer I; Weyergraf A; Mohr P; Strömer K; Augustin M
Hautarzt; 2019 Oct; 70(10):804-810. PubMed ID: 31267179
[TBL] [Abstract] [Full Text] [Related]
14. [Pathologic features on gonadal changes of sexual developmental disorders in children].
Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
[No Abstract] [Full Text] [Related]
15. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
[TBL] [Abstract] [Full Text] [Related]
16. germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
Nogales FF; Prat J; Schuldt M; Cruz-Viruel N; Kaur B; D'Angelo E; Matias-Guiu X; Vidal A; McCluggage WG; Oosterhuis JW
Histopathology; 2018 Mar; 72(4):634-647. PubMed ID: 29106744
[TBL] [Abstract] [Full Text] [Related]
17. Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Pavel ME; Singh S; Strosberg JR; Bubuteishvili-Pacaud L; Degtyarev E; Neary MP; Carnaghi C; Tomasek J; Wolin E; Raderer M; Lahner H; Valle JW; Pommier R; Van Cutsem E; Tesselaar MET; Fave GD; Buzzoni R; Hunger M; Eriksson J; Cella D; Ricci JF; Fazio N; Kulke MH; Yao JC
Lancet Oncol; 2017 Oct; 18(10):1411-1422. PubMed ID: 28838862
[TBL] [Abstract] [Full Text] [Related]
18. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract] [Full Text] [Related]
19. Liver Metastases of Neuroendocrine tumors Rarely Show Overlapping Immunoprofile with Hepatocellular Carcinomas.
Jin M; Zhou X; Yearsley M; Frankel WL
Endocr Pathol; 2016 Sep; 27(3):253-8. PubMed ID: 27300354
[TBL] [Abstract] [Full Text] [Related]
20. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release.
Ganapathy K; Datta I; Sowmithra S; Joshi P; Bhonde R
J Cell Biochem; 2016 Dec; 117(12):2719-2736. PubMed ID: 27064513
[TBL] [Abstract] [Full Text] [Related]
[Next]
